Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Top Cited Papers
- 23 December 2015
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 387 (10022), 957-967
- https://doi.org/10.1016/s0140-6736(15)01225-8
Abstract
No abstract availableThis publication has 65 references indexed in Scilit:
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes MellitusThe New England Journal of Medicine, 2010
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLoS Medicine, 2009
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ, 2009
- Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) ProgramJournal of the American College of Cardiology, 2008
- Telmisartan to Prevent Recurrent Stroke and Cardiovascular EventsThe New England Journal of Medicine, 2008
- Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialThe Lancet, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular diseaseEuropean Heart Journal, 2003
- Randomized Double-Blind Comparison of a Calcium Antagonist and a Diuretic in Elderly HypertensivesHypertension, 1999
- Beta-Blockers Versus Diuretics in Hypertensive Men: Main Results from the HAPPHY TrialJournal of Hypertension, 1987